NYR 14.8% 5.2¢ nyrada inc.

Ann: Brain Injury Program GLP Studies Further Update, page-26

  1. 52 Posts.
    lightbulb Created with Sketch. 3
    Mate what are smoking

    Do you even read what you write. Who’s is Roch your Ex lol

    GLP looks at safety amongst varied animal species so what they dose a human in phase 1 isn’t cytotoxic and what safety results they got before in preclinical studies match up properly and is done by an independent organisation to make sure it’s truthfully done. It’s why they tested in specific human genomes, invitro and invivo.

    Phase 1 needs ethical clearance which takes 3 weeks after GLP results all come out in the next few weeks and they can start phase 1 dosing hence why it’s next quarter phase 1 starts and it’s fully funded but listen into the webinar next week.

    Mate you’re embarrassing your self 2 years to start phase 1, don’t have any cash lol, delisting, don’t even understand that AGN has already proven the mechanism of action of NYR, don’t even understand what a GLP is. You don’t even know what day it is because you MSB posts make me laugh “Guys up 2 cents today, down 2 cents today, company going to $10 dollars a 30 billion dollar market cap lol on FDA approval lol”. Please looking at your other investments like LDX calling 30 cents on a COVID test and now the share price is less than when you were posting. Dont lie and people will listen to your post. Unfortunately your a troll
    Last edited by Bendunstan: 10/08/24
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
5.2¢
Change
-0.009(14.8%)
Mkt cap ! $10.02M
Open High Low Value Volume
5.8¢ 5.8¢ 5.2¢ $12.47K 222.3K

Buyers (Bids)

No. Vol. Price($)
1 16000 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 165000 1
View Market Depth
Last trade - 14.05pm 26/08/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.